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1. Intr~uction 
The development of-a new procedure for isolating 
gangliosides from tissue and separating them on an 
anion exchange resin, Spherosil-DEAE-dextran, 
according to their number of sialic acids has made it 
possible to isolate gangliosides with 3 or more sialic 
acids with a homogenous carbohydrate moiety in a 
high yield [l-3]. We have applied the new procedure 
in the isolation of tetra- and pentasialogangliosides 
from human infant brain. By partial sialidase and 
mild acid hydrolysis, component and methylation 
analysis and mass spectrometry of the permetllylated 
and the permethylated-reduced-silylated derivatives 
of the intact ganglioside, the structure of the major 
tetrasialoganglioside from human brain was shown to 
be: 
Abbreviations and nomenclature: GC-MS, gas-liquid chro- 
matography-mass pectrometry; GalNAc, N-acetylgalactos- 
amine; NeuAc,Nacetylneuraminicacid;cer, ceramide; PTLC, 
high performance liquid chromatography 
Abbreviations for gangliosides follow the nomenclature 
system of Svennerholm, IUPAC-IUB Commission on Bio- 
chemical Nomenclature CBN, The Nomenclature of Lipids 
r141 
GMl, I13NeuAc-GgOse,Cer; GDla, IV’NeuAc, IIsNeuAc- 
GgOse,Cer; GDlb, II”(NeuAc),-GgOse,Cer; GTla, 1V3- 
(NeuAc),, I13NeuAc-GgOse,Cer; GTlb, IV”NeuAc, II’- 
(NeuAc),GgOse,Cer; GQlb, IV’(NeuAc),, I13(NeuAc),- 
GgOse,Cer 
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2. Materials and methods 
2.1. Chemicals 
The materials and methods for isolating a crude 
ganglioside extract and the assay with (TLC) were 
described in [I]. Spherosil-DEAE-dextran, consisting 
of porous glass beads covered with cross-linked DEAE- 
dextran, was prepared as in 121. References sugars 
were puchased from Pfanstiehl Labs., Waukegan, IL. 
Vibrio cholerae sialidase (EC 3.2.18) was from 
Behring-Werke AC, Marburg-Lahn. 
Crude gangliosides were isolated from 500 g of a 
3-month-old human infant forebrain with chloro- 
form/methanol/water (4:8:3, by vol.) and after 
purification [ 1 ] separated on two identical Spherosil- 
DEAE-dextran columns [3]. The gangliosides were 
eluted with a discontinuous gradient of potassium 
acetate in methanol. Tetrasialogangliosides appeared 
in the 0.5 M KAc in methanol effluent. After dialysis 
against water the fraction was redissolved in 10 ml 
chloroformfmethanoI/water (30:60:20, by vol.), and 
undissolved material was removed by centrifugation. 
The solution was then passed through a column of 2 g 
silica gel. The gangliosides were eluted with 40 ml of 
the same solvent. A major tetrasialoganglioside band 
was isolated by chromatography on precoated TLC 
plates developed in 1 -propanol/0.25% aqueous KC1 
(7:3, v/v) for 4 h. The plates were sprayed with 
bromthymol blue, the tetrasialoganglioside band was 
scraped off and eluted from the gel, placed in small 
columns with sintered discs, with chloroform/ 
methanol/water (30:60:20, by vol.). The purity of 
the tetrasialoganglioside fraction was assayed by 
HPTLC in several solvent systems [3]. 
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2.3. Determination of components Table 1 
Sialic acid was assyed with the resorcinol proce- 
dure [4] and the other components with methods 
described in [S]. 
Molar ratio of components of tetrasialoganglioside 
2.4. Partial acid and enzymic degradation 
Partial acid hydrolysis was performed with either 
0.01 M formic acid at 80°C for 30 min or with 1 .O M 
formic acid for 30 min in a boiling water bath. Gan- 
gliosides and neutral glycolipids formed were analysed 
by TLC with solvents and spray reagents described 
in [5]. 
Sphingosine 1.00 
N-Acetylneuraminic a id 3.93 
Glucose 1.03 
&lactose 1.84 
Galactosamine 0.73 
Hydrolysis with Vibrio cholerae sialidase was 
performed in 0.01 M Tris-maleate buffer (pH 6.5) 
containing 4 mM CaCl*. Incubation was done in a 
water bath at 37°C and samples were taken out 
after 15,30 and 60 min. After removal of salts and 
liberated sialic acids on mini-columns with Sephadex 
G-25 [6], the glycolipid products were assayed by 
HPTLC [5]. 
2.5. Periodate oxidation-borohydride reduction 
Periodate oxidation and borohydride reduction 
of the tetrasialoganglioside was performed according 
to [7]. The ganglioside was thereafter subjected to 
methanolysis and with GLC [8] the sialic acids 
were analyzed as their TMS derivatives. 
2.6. Permethylation s&dies 
The ganglioside was permethylated by the method 
in [9], hydrolysed, reduced, acetylated and analysed 
by GC-MS, as in [5]. 
human infant forebrain was found to be 16 pmol 
ganglioside/kg wet wt or 4% of the total lipid-NeuAc. 
The recovery of the tetrasialoganglioside was -80%. 
The molar ratio of the components confirmed that 
it was a tetrasialosylgangliotetraosylceramide (table 1). 
Hydrolysis of the tetrasialoganglioside in 0.01 M 
formic acid led to the formation of roughly equal 
amounts of gangliosides, which at TLC migrated like 
GTla, GTlb, GDla, GDlb and GMl. When 1.0 M 
formic acid was used, the predominant product was 
a glycolipid, which migrated like gangliotetraosyl- 
ceramide. Minor portions of gangliotetraosylceramide 
and lactosylceramide were also formed. On TLC the 
primary product of hydrolysis after sialidase treat- 
ment of the tetrasialoganglioside migrated like 
authentic GTlb. Continued hydrolysis led to the for- 
mation of ganglioside GDl b and minor amounts of 
GDla(the ratio was 10-20: 1 in different experiments). 
The final product was ganglioside GM1 , which was 
identified by comparing its capacity to bind cholera 
toxin with authentic GM1 [ 121. 
2.7. Mass spectrometnk analyses 
The gangliosides were permethylated according to 
[9], reduced with LiAlH4 and silylated [lo]. The 
mass spectrometer used was a MS 902 instrument 
(AEI Ltd, Manchester). The handling of the samples 
has been discussed in [lo]. To obtain fragments of 
higher weight the temperature of the ion source was 
adjusted to the evaporation temperature of the 
sample, and the sample cuvette was placed just in the 
electron beam [l l]. The mass numbers were obtained 
by counting by hand and are therefore nominal 
masses. Owing to the high content of hydrogen atoms 
(mass 1.008) the exact masses in the upper regions 
are one unit higher than those reproduced. 
Mass spectra of derivatives of the intact ganglioside 
provide conclusive evidence for the GQlb sequence. 
The cluster of ions seen at m/e 2747 in fig.1 and pro- 
duced from the permethylated-recluced derivative is 
characteristic [10,13] of the complete saccharide and 
the fatty acid (see top formula). This supports the 
data in table 1 giving all together 8 sugars including 
4 sialic acids. Specific primary octasaccharide ions are 
indicated at m{e 2422,2438 and 2452, and these 
may lose a varying number of mass units including 
part of a sialic acid (e.g., 391 mass units, which is 
406-15). This is shown at m/e 1235, 1640,2031, 
2350,2364 and 2378. 
3. Results and discussion 
The concentration of the tetrasialoganglioside of 
The sequence of the 8 sugars is inferred from a 
number of peaks in both spectra. A terminal saccha- 
ride of two sialic acids is shown in fig.1 by peaks at 
m/e 360,374,390,392,406 and 797, and in fig.2 by 
peaks at m/e 330,344,362,376,677 and 737. There 
is no evidence of a trisaccharide of sialic acids 
(expected at m/e 1188 in fig.1 or 1098 in fig.2). Two 
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Fig.1. Mass spectrum of the permethylated, reduced and trimethylsilylated ganglioside. The formula above the spectrum gives the 
major molecular species found. Ions were recorded in the molecular peak region (m/e 3000), but their nominal masses were 
uncertain and therefore not included in the figure. The peaks at m/e 360,374,390, 392,406 and 407 exceeded the range of the 
oscillographic recording but are given as 100% in the figure. Ions below m/e 350 were not recorded. The sample cuvette was 
introduced just at the electron beam (in-beam technique) at an ion source temperature of 280°C. Further conditions of analysis 
were: electron energy 38 eV; trap current, 500 PA; acceleration voltage, 3 kV. 
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Fig.2. Mass spectrum of the permethylated ganglioside. The formula above the spectrum gives the major molecular species found. 
The sample cuvette was introduced just in the electron beam (in-beam technique) at an ion source temperature of 280°C. Further 
conditions of analysis were: electron energy 28 eV; trap current 500 PA; acceleration voltage, 4 kV. 
rather intense peaks at m/e 1112 and 1126 in fig.2 ceramide is shown by the peak at m/e 530 in fig.1 
are produced by the terminal tetrasaccharide rest, which also contains stearic acid. 
sialyl-sialyl-hexosyl-hexosaminyl. Addition of the Analysis of the permethylated sugars from the 
inner galactose with two sialic acids to this terminal tetrasialoganglioside by GLC and CC-MS showed 
tetrasaccharide gives the peak at m/e 2084 in fig.2. that it contained 2,3,6-tri-U-methylglucitol, 2,4,6- 
The 4 sialic acids should therefore be located as tri-U-methylgalactitol, 2,6-d&0-methylgalactitol and 
shown in the formula. That hexose is bound to 4,6-di-O-methyl-2-deoxy-2-N-methylacetamidogalac- 
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titol. The permethylation studies showed that sialic 
acid is linked to both the internal and the external 
galactose molecules in a 2+3 linkage. The periodate 
oxidation and borohydride reduction gave rise to 
approximately equal amounts of intact sialic acid 
and the 7-carbon derivative of sialic acid, indicating 
that 2 of the 4 sialic acids were substituted at the C8 
position. The combined results of the mass spectro- 
metric analysis, the component analysis and the 
studies of the partially methylated alditol acetates 
suggest he following structural formula for the 
tetrasialoganglioside isolated from human brain: 
~l~1-t~~l-t4GalB1-t4Glc~1~1~ 
/3 /3 
New2 NeuAco2 
.8 /8 
New2 NeuAox2 
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